Aandelen in “Biotechnologie”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Biotechnologie”

04:35 · Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? · Persbericht

04:35 · Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders? · Persbericht

04:00 · Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN · Persbericht

00:01 · Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration · Persbericht

25/09 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

25/09 · Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

25/09 · Immunovant Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Immunovant (IMVT) · Persbericht

25/09 · Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS · Persbericht

25/09 · IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) · Persbericht

25/09 · Addex Regains Rights to GABAB Positive Allosteric Modulator Portfolio from Indivior · Persbericht

25/09 · REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting · Persbericht

24/09 · NANOBIOTIX Provides First Half 2026 Operational and Financial Update · Persbericht

24/09 · CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline · Persbericht

24/09 · Availability of Transgene’s Half-Year Financial Report as of June 30, 2026 · Persbericht

24/09 · 2026 Half-Year Financial Report · Persbericht

24/09 · Transgene Extends its myvac® Platform, Further Establishing its Position as a Key Player in the Rapidly Emerging Individualized Cancer Immunotherapy Field · Persbericht

24/09 · SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 16, 2026 in Ardelyx, Inc. Lawsuit - ARDX · Persbericht

24/09 · SueWallSt Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - CAPR · Persbericht

24/09 · LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads · Persbericht

24/09 · Viking Therapeutics Prices Upsized $500 Million Offering of Common Stock and Convertible Senior Notes · Persbericht

24/09 · Carbios reports first-half 2026 results · Persbericht

Mijn selecties